When we treated SS model mice with an anti-murine FasL-specific monoclonal antibody to protect against Fas-mediated apoptosis of the target salivary gland cells (111), we unexpectedly observed exacerbation of the autoimmune lesions in the salivary and lacrimal glands (111). The gene discussed is FAS; the disease is synovial sarcoma.